ANIKA THERAPEUTICS INC (ANIK)

US0352551081 - Common Stock

16.33  +0.1 (+0.62%)

ANIKA THERAPEUTICS INC

NASDAQ:ANIK (12/24/2024, 7:55:28 PM)

16.33

+0.1 (+0.62%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%44.44%
Sales Q2Q%-6.54%
CRS10.59
6 Month-35.53%
Overview
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)N/A N/A
Ins Owners2.85%
Inst Owners92.08%
Market Cap239.23M
Shares14.65M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts87.5
Short Float %2.6%
Short Ratio3.59
IPO05-16 1985-05-16
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ANIK Daily chart

Company Profile

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. The company is headquartered in Bedford, Massachusetts and currently employs 357 full-time employees. The firm creates and delivers advancements in early intervention orthopedic care, including in the areas of osteoarthritis (OA) pain management, regenerative solutions, and sports medicine. The company is focused on developing, manufacturing and commercializing products on its hyaluronic acid (HA), technology platform. Its OA Pain Management product family consists of Monovisc and Orthovisc, its injectable, HA, OA Pain Management offerings are indicated to provide pain relief from osteoarthritis conditions; and Cingal, its novel, next generation, single-injection OA Pain Management product consisting of its proprietary cross-linked HA material combined with a steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products utilizing HA, including Integrity, its new hyaluronic acid-based scaffold for rotator cuff and other tendon repairs.

Company Info

ANIKA THERAPEUTICS INC

32 Wiggins Ave

Bedford MASSACHUSETTS 01730

P: 17814579000

CEO: Cheryl R. Blanchard

Employees: 357

Website: https://anika.com/

ANIK News

News Image3 days ago - Anika Therapeutics Inc.Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
News Image3 days ago - Anika Therapeutics Inc.Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

News Image21 days ago - Market News VideoNoteworthy Thursday Option Activity: SB, AEO, ANIK
News Image23 days ago - Market News VideoAnika Therapeutics Enters Oversold Territory (ANIK)
News Imagea month ago - Anika Therapeutics Inc.Anika To Participate in December 2024 Investor Conferences
News Imagea month ago - Anika Therapeutics Inc.Anika To Participate in December 2024 Investor Conferences

BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...

ANIK Twits

Here you can normally see the latest stock twits on ANIK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example